Table 1:
Number of individuals diagnosed with oropharyngeal, oral cavity, or hypopharyngeal/laryngeal squamous cell carcinomas in the SEER Cancer Registry (1973–2015) by covariate and number of people at risk (i.e., not dead or censored) 5, 10, and 15 years after diagnosis.
Covariate | At diagnosis | 5 years | 10 years | 15 years | ||||
---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | |
All | 180,434 | 69,469 | 33,066 | 13,722 | ||||
Age | ||||||||
<50 | 24,386 | 13.5% | 12,309 | 17.7% | 7,317 | 22.1% | 3,661 | 26.7% |
50–59 | 52,689 | 29.2% | 22,372 | 32.2% | 11,406 | 34.5% | 5,027 | 37.0% |
60–69 | 55,881 | 31.0% | 21,348 | 30.7% | 9,746 | 29.5% | 3,873 | 28.2% |
70+ | 47,478 | 26.3% | 13,440 | 19.3% | 4,597 | 13.6% | 1,161 | 8.5% |
Sex | ||||||||
Male | 135,416 | 75.1% | 51,986 | 74.8% | 24,503 | 74.1% | 9,964 | 72.6% |
Female | 45,018 | 24.9% | 17,483 | 25.2% | 8,563 | 25.9% | 3,758 | 27.4% |
Race | ||||||||
White | 150,160 | 83.2% | 59,845 | 86.1% | 28,565 | 86.4% | 11,870 | 86.5% |
Black | 21,563 | 12.0% | 6,263 | 9.0% | 2,818 | 8.5% | 1,107 | 8.1% |
Other/unknown | 8,711 | 4.8% | 3,361 | 4.8% | 1,683 | 5.1% | 745 | 5.4% |
Anatomical site | ||||||||
Oropharynx | 60,859 | 33.7% | 21,579 | 31.1% | 9,110 | 27.6% | 2,943 | 21.4% |
Oral cavity | 48,834 | 27.1% | 18,444 | 26.5% | 8,592 | 26.0% | 3,881 | 28.3% |
Hypopharynx & larynx | 70,741 | 39.2% | 29,446 | 42.4% | 15,004 | 45.4% | 6,898 | 50.3% |
Tumor stage | ||||||||
Localized | 47,790 | 26.5% | 27,098 | 39.0% | 15,829 | 47.9% | 7,854 | 57.2% |
Regional | 80,653 | 44.7% | 28,422 | 40.9% | 13,237 | 40.0% | 4,853 | 35.4% |
Distant | 19,212 | 10.6% | 3,356 | 4.8% | 1,230 | 3.7% | 524 | 3.8% |
Unstaged | 32,779 | 18.2% | 10,593 | 15.2% | 2,770 | 8.4% | 599 | 4.4% |
Year of diagnosis | ||||||||
1973–1984 | 24,863 | 13.8% | 10,998 | 15.8% | 7,093 | 21.5% | 4,482 | 32.7% |
1985–1999 | 39,461 | 21.9% | 18,504 | 26.6% | 12,042 | 36.4% | 7,840 | 57.1% |
2000–2015* | 116,110 | 64.4% | 39,967 | 57.5% | 13,931 | 42.1% | 1,400 | 10.2% |
More recent diagnoses have not yet made it to 5, 10, or 15 years after diagnosis.